...
首页> 外文期刊>Journal of Ayurveda and Integrative Medicine >Original Research Article (Experimental) Ayurvedic anti-diabetic formulation Lodhrasavam inhibits alpha-amylase, alpha-glucosidase and suppresses adipogenic activity in?vitro
【24h】

Original Research Article (Experimental) Ayurvedic anti-diabetic formulation Lodhrasavam inhibits alpha-amylase, alpha-glucosidase and suppresses adipogenic activity in?vitro

机译:原始研究文章(实验性)阿育吠陀抗糖尿病药Lodhrasavam在体外抑制α-淀粉酶,α-葡萄糖苷酶并抑制成脂活性

获取原文
           

摘要

Background The patho-physiological cross-talk between diabetes and obesity is well established. However, the choices of drugs suitable for combined treatment of diabetes and obesity are limited. Integration of complementary and alternative medicines (CAMs), like Ayurveda, with modern medicine would be a promising strategy to fill this gap. The diagnostic principles of Ayurveda define obesity as one of the predisposing factors of Madhumeha (correlated as diabetes) and recommends specific formulations for managing obese-diabetes. Lodhrasavam is one such poly-herbal formulation prescribed for obese-diabetic patients. Objectives The present study is an attempt to demonstrate the possible modes of action of Lodhrasavam , built on the hypothesis that the formulation can exert both anti-diabetic and anti-obesity actions. Materials and methods Lodhrasavam , following simulated gastro-intestinal digestion, was monitored for inhibition of α-amylase, α-glucosidase (key digestive enzyme targets of anti-diabetic drugs) and adipogenesis using standard in vitro model systems. Results Lodhrasavam digest inhibited α-amylase (90%) and α-glucosidase (78%) activity as well as reduced the differentiation of 3T3-L1 fibroblasts to adipocytes. Upon fractionation, the enzyme inhibitory activity and anti-adipogenic activity of the digest were found distributed in different solvent fractions. This partly indicates a potential pharmacological networking of chemically and functionally diverse bioactive molecules in Lodhrasavam. Conclusion The study provides a possible mode of action and an experimental support for the Ayurvedic use of Lodhrasavam for managing obese-diabetes. Generating scientific evidences and understanding the modes of action, in contemporary scientific language, would essentially help in expanding global acceptance of potentials of CAMs in the management of life style disorders.
机译:背景技术糖尿病和肥胖症之间的病理生理学相互作用已得到很好的确立。但是,适合于糖尿病和肥胖症的联合治疗的药物选择受到限制。将印度药草(Ayurveda)等辅助和替代药物(CAMs)与现代医学相结合将是填补这一空白的有希望的战略。阿育吠陀的诊断原则将肥胖定义为Madhumeha(与糖尿病相关)的诱发因素之一,并建议用于治疗肥胖糖尿病的特定配方。罗汉果(Lodhrasavam)是为肥胖糖尿病患者开出的一种此类多草药配方。目的本研究是基于该制剂可同时发挥抗糖尿病和抗肥胖作用的假设,试图证明罗得沙姆可能的作用方式。材料和方法在模拟胃肠道消化后,使用标准的体外模型系统监测Lodhrasavam对α-淀粉酶,α-葡萄糖苷酶(抗糖尿病药物的关键消化酶靶标)的抑制和成脂作用。结果Lodhrasavam消化物抑制α-淀粉酶(90%)和α-葡萄糖苷酶(78%)活性,并减少3T3-L1成纤维细胞向脂肪细胞的分化。分馏后,发现消化物的酶抑制活性和抗脂肪形成活性分布在不同的溶剂组分中。这部分地表明了罗得沙姆中化学和功能多样的生物活性分子的潜在药理网络。结论该研究为罗汉松的印度草药治疗肥胖糖尿病提供了可能的作用方式和实验支持。用当代科学语言生成科学证据并理解作用方式,将实质上有助于扩大全球对CAM在生活方式障碍管理中的潜力的接受程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号